Literature DB >> 1544887

Carnitine administration to juvenile visceral steatosis mice corrects the suppressed expression of urea cycle enzymes by normalizing their transcription.

M Horiuchi1, K Kobayashi, M Tomomura, M Kuwajima, Y Imamura, T Koizumi, H Nikaido, J Hayakawa, T Saheki.   

Abstract

Previous studies in our laboratories have revealed that juvenile visceral steatosis mice show suppressed transcription of urea cycle enzyme genes during development and are systemically deficient in carnitine. It has not yet been explained, however, how this carnitine deficiency relates to the abnormal gene expression. We investigated the effect of carnitine on abnormal gene expression, growth retardation, and fatty liver. Carnitine administration relieved the suppression of the developmental induction of two urea cycle enzymes examined, carbamoyl-phosphate synthetase and argininosuccinate synthase, and kept the activities of enzymes normal. However, carnitine did not reduce accumulated lipid in the liver to the normal level. These results suggest that carnitine deficiency plays an important role in the abnormal expression of urea cycle enzyme genes and that the abnormal expression of the genes is not directly caused by lipid accumulation in the liver.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1544887

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  9 in total

1.  Genomic interval engineering of mice identifies a novel modulator of triglyceride production.

Authors:  Y Zhu; M C Jong; K A Frazer; E Gong; R M Krauss; J F Cheng; D Boffelli; E M Rubin
Journal:  Proc Natl Acad Sci U S A       Date:  2000-02-01       Impact factor: 11.205

2.  Mapping of jvs (juvenile visceral steatosis) gene, which causes systemic carnitine deficiency in mice, on chromosome 11.

Authors:  H Nikaido; M Horiuchi; N Hashimoto; T Saheki; J Hayakawa
Journal:  Mamm Genome       Date:  1995-05       Impact factor: 2.957

Review 3.  Transcriptional regulation of genes for ornithine cycle enzymes.

Authors:  M Takiguchi; M Mori
Journal:  Biochem J       Date:  1995-12-15       Impact factor: 3.857

Review 4.  Prevention of ammonia and glutamate neurotoxicity by carnitine: molecular mechanisms.

Authors:  Marta Llansola; Slaven Erceg; Mariluz Hernández-Viadel; Vicente Felipo
Journal:  Metab Brain Dis       Date:  2002-12       Impact factor: 3.584

5.  Hyperammonemia in carnitine-deficient adult JVS mice used by starvation.

Authors:  Xiang Xian Li; Keiko Kobayashi; Masahisa Horiuchi; Abdul Jalil; Goichiro Yoshida; Takeyori Saheki
Journal:  Metab Brain Dis       Date:  2002-12       Impact factor: 3.584

6.  Identification of human CDV-1R and mouse Cdv-1R, two novel proteins with putative signal peptides, especially highly expressed in testis and increased with the male sex maturation.

Authors:  Jisong Peng; Long Yu; Masahisa Horiuchi; Pingzhao Zhang; Xinghua Huang; Yazhou Zhang; Dan Li; Md Abdul Jalil; Shouyyan Zhao
Journal:  Mol Biol Rep       Date:  2002-12       Impact factor: 2.316

7.  Mitochondrial abnormalities of muscle tissue in mice with juvenile visceral steatosis associated with systemic carnitine deficiency.

Authors:  J Miyagawa; M Kuwajima; T Hanafusa; K Ozaki; H Fujimura; A Ono; R Uenaka; I Narama; T Oue; K Yamamoto
Journal:  Virchows Arch       Date:  1995       Impact factor: 4.064

8.  Levocarnitine Use Is Associated With Improvement in Sarcopenia in Patients With Liver Cirrhosis.

Authors:  Akira Hiramatsu; Hiroshi Aikata; Shinsuke Uchikawa; Kazuki Ohya; Kenichiro Kodama; Yuno Nishida; Kana Daijo; Mitsutaka Osawa; Yuji Teraoka; Fumi Honda; Yuki Inagaki; Kei Morio; Reona Morio; Hatsue Fujino; Takashi Nakahara; Eisuke Murakami; Masami Yamauchi; Tomokazu Kawaoka; Daiki Miki; Masataka Tsuge; Michio Imamura; Junko Tanaka; Kazuaki Chayama
Journal:  Hepatol Commun       Date:  2019-01-22

9.  Case report: Is exchange transfusion a possible treatment for metabolic decompensation in neonates with methylmalonic aciduria in the setting of limited resources?

Authors:  Xiaoyu Cui; Na Li; Hong Xue; Fang Zhang; Jianbo Shu; Yang Liu
Journal:  Front Pediatr       Date:  2022-07-25       Impact factor: 3.569

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.